Session Details
[29-12-am]Clinical Pharmacy 10, Appropriate use of medicines/Pharmacotherapies (Clinical)
Sun. Mar 29, 2026 9:30 AM - 11:30 AM JST
Sun. Mar 29, 2026 12:30 AM - 2:30 AM UTC
Sun. Mar 29, 2026 12:30 AM - 2:30 AM UTC
Room 12 (C403, Bldg. 2, Area 2 [4F])
Chair: Hideki Hayashi, Kazuya Ooi
[29-12-am01]A survey of junior high school teachers’ awareness regarding over-the-counter drug overdose education
○Yoshiaki Matsumoto1, Yuri Ando1, Michihiro Fujiwara2 (1. Adv. Child Care & Education Course, Kyushu Women’s Jr. College, 2. Fukuoka Univ.)
[29-12-am02S]Influence of components in treats on absorption of cyclosporine fine granules
○Momoka Toda1, Yoko Urashima1, Eriko Nagai2, Takahiro Sugimoto2, Satoko Inoue2, Kazuki Umemoto1, Tokio Obata1 (1. Pharm., Osaka Ohtani Univ., 2. Pharm., Osaka Women's and Children's Hospital.)
[29-12-am03S]Effects of kampo medicines containing mineral crude drugs on absorption of antibacterial agents
○Kirara Ono1, Kazuki Umemoto1, Yoko Urashima1, Tokio Obata1 (1. Pharm., Osaka Ohtani Univ.)
[29-12-am04S]A Survey on the Prescription Patterns of Antiemetic Drugs in Low- and Minimal-Emetogenic Chemotherapy
○Takumi Arafune1, Masami Tsuchiya1, Yuki Yanagisawa1, Hayato Kizaki1, Shungo Imai1, Satoko Hori1 (1. Keio univ. Pharm.)
[29-12-am05S]Time to onset of immune-related adverse events with nivolumab–ipilimumab combination therapy versus nivolumab monotherapy using a drug adverse event database
○Midori Nishiguchi1, Satoshi Noda1,2, Yoshito Ikeda1, Shin-ya Morita1 (1. Grad. Sch. Med. Sci., Shiga Univ. of Med. Sci., 2. Coll. Pharm. Sci., Ritsumeikan Univ.)
[29-12-am06]An Examination of How Outpatient Non-Infectious Disease Prescriptions Influence the Access Ratio in the AWaRe Classification
○Satoko Karakl1, Motoki Kei1, Shiori Sato1, Hiromi Sugahara1, Toshimasa Ito1 (1. Tokyo Women's Medical University,Adachi Medical Center)
[29-12-am07S]Inter-formulation differences in lung deposition prediction models based on particle emission signals
○Sakiko Hatazoe1,2, Daiki Hira1, Mika Takema1, Tetsuri Kondo3, Yuki Shigetsura1, Natsuki Imayoshi1, Yurie Katsube1, Keiko Ikuta1, Yuki Kunitsu1, Satoshi Ueshima4, Shunsaku Nakagawa1, Masahiro Tsuda1, Mikio Kakumoto4, Tomohiro Terada1 (1. Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, 2. Graduate School of Pharmaceutical Sciences, Kyoto University, 3. Department of Respiratory Medicine, Shonan Fujisawa Tokushukai Hospital, 4. College of Pharmaceutical Sciences, Ritsumeikan University)
[29-12-am08S]An investigation of treatment patterns among patients with type 2 diabetes in Japan
○Risako Onoda1, Suzu Uetsuki1, Manato Yoshida1, Akinori Oh1, Ryoko Sakai1, Manabu Akazawa1 (1. Meiji pharmaceutical Univ)
[29-12-am09]Effectiveness and safety of subcutaneous methotrexate in Japanese patients with rheumatoid arthritis: A single center retrospective study
○Eri Nakao1, Taketo Ezaki2, Sho Masui2, Kodai Yajima2, Hitoshi Kawazoe1,2,3, Atsushi Yonezawa2, Hisakazu Ohtani1,2,3 (1. Dept. of Pharmacy, Keio Univ. Hosp., 2. Sch. Pharm., Keio Univ., 3. Sch. Med., Keio Univ.)
[29-12-am10S]Comparative investigation of plasma concentration analysis methods for three drugs using LC–quadrupole time-of-flight MS/MS and a conventional method
○Taichi Isono1, Masamitsu Maekawa1,2, Yu Sato2,3, Toshihiro Sato2,4, Masaki Kumondai2, Taku Tsukamoto5, Yoshihiro Hayakawa5, Nariyasu Mano1,2 (1. Fac. Pharm. Sci., Tohoku Univ., 2. Dept. Pharm. Sci., Tohoku Univ. Hosp., 3. Fac. Pharm. Sci., Tohoku Med. and Pharm. Univ., 4. Dept. Pharm., Yamagata Univ. Hosp., 5. Shimadzu Corp.)
